Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Mar;75(3):915–920. doi: 10.1172/JCI111792

Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization.

R S Weening, L Corbeel, M de Boer, R Lutter, R van Zwieten, M N Hamers, D Roos
PMCID: PMC423624  PMID: 3980731

Abstract

Three patients (two sisters and a brother) in one family are described with chronic granulomatous disease. The granulocytes of these patients did not respond with a metabolic burst to various stimuli and failed to kill catalase-positive microorganisms. The magnitude of the cytochrome b signal in the optical spectrum of the patients' granulocytes was less than 4% of the normal value, whereas the amount of noncovalently bound flavin in these cells was normal. The mode of inheritance of the genetic defect in this family is autosomal because the granulocytes of both parents (first cousins) and a nonaffected sister of the patients expressed 70-80% of the normal cytochrome b signal, showed low-normal or subnormal oxidative reactions during stimulation, and did not display mosaicism in the stimulated nitroblue-tetrazolium slide test. Somatic cell hybridization was performed between the monocytes from the affected boy in this family with monocytes from either a cytochrome b-negative male patient with X-linked chronic granulomatous disease or a cytochrome b-positive male patient with the classic autosomal form of this disease. In both combinations, monocyte hybrids were observed with nitroblue tetrazolium reductase activity after stimulation with phorbol myristate acetate. This complementation of the oxidase activity required protein synthesis. Our results prove that the defect in this family is genetically distinct from that in the other two forms of chronic granulomatous disease. Moreover, our results also indicate that the expression of cytochrome b in human phagocytes is coded by at least two loci, one on the X chromosome and one on an autosome.

Full text

PDF
915

Images in this article

917Image
on p.917
917Image
on p.917

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babior B. M. Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med. 1978 Mar 30;298(13):721–725. doi: 10.1056/NEJM197803302981305. [DOI] [PubMed] [Google Scholar]
  2. Borregaard N., Cross A. R., Herlin T., Jones O. T., Segal A. W., Valerius N. H. A variant form of X-linked chronic granulomatous disease with normal nitroblue tetrazolium slide test and cytochrome b. Eur J Clin Invest. 1983 Jun;13(3):243–248. doi: 10.1111/j.1365-2362.1983.tb00095.x. [DOI] [PubMed] [Google Scholar]
  3. Borregaard N., Tauber A. I. Subcellular localization of the human neutrophil NADPH oxidase. b-Cytochrome and associated flavoprotein. J Biol Chem. 1984 Jan 10;259(1):47–52. [PubMed] [Google Scholar]
  4. Corbeel L., Weening R. S., Roos D., Stadsbaeder S., Geboes K., Standaert L., Eggermont E., Casteels-Van Daele M., Delmotte B., Eeckels R. Familial deficiency of granulocyte bactericidal capacity associated with growth retardation. Acta Paediatr Belg. 1978 Jan-Mar;31(1):15–25. [PubMed] [Google Scholar]
  5. Cross A. R., Jones O. T., Garcia R., Segal A. W. The association of FAD with the cytochrome b-245 of human neutrophils. Biochem J. 1982 Dec 15;208(3):759–763. doi: 10.1042/bj2080759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FORD D. K., PRICE G. E., CULLING C. F., VASSAR P. S. Familial lipochrome pigmentation of histiocytes with hyperglobulinemia, pulmonary infiltration, splenomegaly, arthritis and susceptibility to infection. Am J Med. 1962 Oct;33:478–489. doi: 10.1016/0002-9343(62)90259-0. [DOI] [PubMed] [Google Scholar]
  7. Faeder E. J., Siegel L. M. A rapid micromethod for determination of FMN and FAD in mixtures. Anal Biochem. 1973 May;53(1):332–336. doi: 10.1016/0003-2697(73)90442-9. [DOI] [PubMed] [Google Scholar]
  8. Figdor C. G., Bont W. S., De Vries J. E., Van Es W. L. Isolation of large numbers of highly purified lymphocytes and monocytes with a modified centrifugal elutriation technique. J Immunol Methods. 1981;40(3):275–288. doi: 10.1016/0022-1759(81)90359-8. [DOI] [PubMed] [Google Scholar]
  9. Gabig T. G., Lefker B. A. Deficient flavoprotein component of the NADPH-dependent O2-.-generating oxidase in the neutrophils from three male patients with chronic granulomatous disease. J Clin Invest. 1984 Mar;73(3):701–705. doi: 10.1172/JCI111262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goetzl E. J., Foster D. W., Goldman D. W. Isolation and partial characterization of membrane protein constituents of human neutrophil receptors for chemotactic formylmethionyl peptides. Biochemistry. 1981 Sep 29;20(20):5717–5722. doi: 10.1021/bi00523a013. [DOI] [PubMed] [Google Scholar]
  11. Goldstein I. M., Roos D., Kaplan H. B., Weissmann G. Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest. 1975 Nov;56(5):1155–1163. doi: 10.1172/JCI108191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hamers M. N., de Boer M., Meerhof L. J., Weening R. S., Roos D. Complementation in monocyte hybrids revealing genetic heterogeneity in chronic granulomatous disease. Nature. 1984 Feb 9;307(5951):553–555. doi: 10.1038/307553a0. [DOI] [PubMed] [Google Scholar]
  13. Lutter R., van Zwieten R., Weening R. S., Hamers M. N., Roos D. Cytochrome b, flavins, and ubiquinone-50 in enucleated human neutrophils (polymorphonuclear leukocyte cytoplasts). J Biol Chem. 1984 Aug 10;259(15):9603–9606. [PubMed] [Google Scholar]
  14. Roos D., Voetman A. A., Meerhof L. J. Functional activity of enucleated human polymorphonuclear leukocytes. J Cell Biol. 1983 Aug;97(2):368–377. doi: 10.1083/jcb.97.2.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Segal A. W., Cross A. R., Garcia R. C., Borregaard N., Valerius N. H., Soothill J. F., Jones O. T. Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance. N Engl J Med. 1983 Feb 3;308(5):245–251. doi: 10.1056/NEJM198302033080503. [DOI] [PubMed] [Google Scholar]
  16. Segal A. W., Jones O. T. Absence of cytochrome b reduction in stimulated neutrophils from both female and male patients with chronic granulomatous disease. FEBS Lett. 1980 Jan 28;110(1):111–114. doi: 10.1016/0014-5793(80)80035-4. [DOI] [PubMed] [Google Scholar]
  17. Segal A. W., Jones O. T. Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature. 1978 Nov 30;276(5687):515–517. doi: 10.1038/276515a0. [DOI] [PubMed] [Google Scholar]
  18. Tauber A. I., Borregaard N., Simons E., Wright J. Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies. Medicine (Baltimore) 1983 Sep;62(5):286–309. [PubMed] [Google Scholar]
  19. Tauber A. I., Brettler D. B., Kennington E. A., Blumberg P. M. Relation of human neutrophil phorbol ester receptor occupancy and NADPH-oxidase activity. Blood. 1982 Aug;60(2):333–339. [PubMed] [Google Scholar]
  20. Voetman A. A., Bot A. A., Roos D. Cryopreservation of enucleated human neutrophils (PMN cytoplasts). Blood. 1984 Jan;63(1):234–237. [PubMed] [Google Scholar]
  21. Weening R. S., Roos D., Loos J. A. Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study. J Lab Clin Med. 1974 Apr;83(4):570–577. [PubMed] [Google Scholar]
  22. Wever R., Plat H., Hamers M. N. Human eosinophil peroxidase: a novel isolation procedure, spectral properties and chlorinating activity. FEBS Lett. 1981 Jan 26;123(2):327–331. doi: 10.1016/0014-5793(81)80320-1. [DOI] [PubMed] [Google Scholar]
  23. Wong L., Wilson J. D. The identification of Fc and C3 receptors on human neutrophils. J Immunol Methods. 1975 Apr;7(1):69–76. doi: 10.1016/0022-1759(75)90131-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES